Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids Using the HEM-AVERT Perianal Stabilizer Instrument

Hemorrhoids Clinical Trial

— HEM-AVERT  

Official title:

Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids (TEH) Using the HEM-AVERT Perianal Stabilizer Instrument

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00487045
• Other study ID #: PB_001
• Status: Completed
• Phase: Phase 1
• First received: June 13, 2007
• Last updated: July 23, 2009
• Start date: December 2007
• Est. completion date: June 2009

Study information

• Verified date: July 2009
• Source: Plexus Biomedical, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug AdministrationUnited States: BMHCC Instituitonal Review Board
• Study type: Interventional

Clinical Trial Summary

This study is being conducted to evaluate an investigational instrument called the HEM-AVERT Perianal Stabilizer and its efficacy in reducing the occurrence or severity of hemorrhoids and thrombosed external hemorrhoids (TEH) which commonly occur during vaginal delivery.

Description:

This study is being conducted to evaluate an investigational instrument called the HEM-AVERT™ Perianal Stabilizer and its efficacy in reducing the occurrence or severity of hemorrhoids and thrombosed external hemorrhoids (TEH). Hemorrhoids and TEH are caused by blood pooling in a distended vein and forming a clot, or thrombose, in the outer region of the anus. An anal fissure is a small split or tear in the anal mucosa that may result in painful bowel movements and bleeding. Like hemorrhoids, anal fissures are common in women after childbirth. Lacerations are graded as first, second, third and fourth degree. First and second degree are perineal lacerations and involve the mucosa and perineum and usually heal by themselves. First and second degree lacerations are considered to be a normal occurrence in child birth. Third degree lacerations involve the anal sphincter and fourth degree lacerations involve the sphincter and mucosa of the anus with bowel involvement and usually require surgical repair. Per the product classification that was assigned to this instrument by the FDA, the instrument is both non-invasive and posses a non-significant risk. It is classified as a manual, general instrument with no specific indications, but has a general indication of stabilizing pressure. The purpose of this clinical study is to collect data to support a 510(k) application to obtain the specific indication of preventing the occurrence of hemorrhoids, or reducing the severity of hemorrhoids which often occur during vaginal deliveries. Hemorrhoids and TEH represent common adverse events in vaginal births with reported occurrences ranging from a low of 9% to a high of 34% in the reported literature. Currently no preventative treatment exists. There will be two study groups; an investigational group (subjects receiving the HEM-AVERT™ instrument) and the control group (subjects will not receive the HEM-AVERT™ instrument). The HEM-AVERT™ Perianal Stabilizer is a Class 1, exempt device in accordance with FDA regulation 21 CFR 890.5765. The HEM-AVERT™ is a non-invasive instrument used to provide continuous pressure to the perianal region as a means to help provide support during the labor process. Each HEM-AVERT™ instrument is a single use, disposable, sterile, individually packaged instrument. The HEM-AVERT™ instrument consists of three components: 1) a rigid polymer base manufactured from a medical grade polycarbonate; 2) a centrally located cushioning pad which is composed of a laminate of medical grade polyester non-woven tape and medical grade polyethylene foam tape; and 3) two lateral hook and loop fastener adhesive strips (with liners) ("loop" strips that attach to the mating "hook" [similar to VELCRO®]) which is used to provide the tension needed to keep the instrument firmly in place during delivery. The cushioning pad and adhesive strips are manufactured using materials commonly found in medical instruments and used in medical procedures. All of the materials used to manufacture this instrument meet the available national or international standards specifications as applied to this instrument. This instrument is not to be implanted.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 176
• Est. completion date: June 2009
• Est. primary completion date: June 2009
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Subject is between 18 and 40 years of age, female and pregnant.

• Subject weighs 130 pounds or greater at time of delivery.

• Subject is scheduled for vaginal delivery.

• Subject is willing and able to comply with the study plan as indicated by understanding and signing the Subject Informed Consent Form.

• Subject's pre-natal examination indicates that this is to be a single birth delivery.

• Subject has no current hemorrhoids or has low grade hemorrhoids.

• Subject's with previous history of hemorrhoids that are visually asymptomatic at time of screening (history) and physical examination are also acceptable

• Subject has no lacerations or anal fissures

• Subject is not a prisoner

Exclusion Criteria:

• Subject is younger than 18 years of age or older than 40 years of age.

• Subject weighs less than 130 pounds at time of delivery.

• Subject has hemorrhoids other than low grade

• Subject has had previous rectal surgery (e.g., hemorrhoidectomy)

• Subject has lacerations or anal fissures

• Subject has a documented allergy to the instrument's materials.

• Subject's scheduled for vaginal delivery with anticipated complications [such as breech presentation]

• Subject is unable to understand and sign the informed consent form.

• Subject is a prisoner.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hemorrhoids
• Thrombosis

Intervention

Device:
• Hem-Avert Perianal Stabilizer
Hem-Avert Perianal Stabilizer, TNP-01L, single-use, disposable, sterile, individually packaged instrument

Locations

Country	Name	City	State
United States	Baptist Memorial Hospital-Tipton	Covington	Tennessee
United States	Baptist Women's Hospital	Memphis	Tennessee
United States	Baptist Memorial Hospital-Desoto	Southaven	Mississippi

Sponsors (2)

Lead Sponsor	Collaborator
Plexus Biomedical, Inc.	Baptist Memorial Health Care Corporation

Country where clinical trial is conducted

United States, 

References & Publications (1)

Abramowitz L. et.al. Epidemiology of anal fissures (fissure and thrombosed external hemorrhoid) during pregnancy and post-partum. Gynecxologie Obstetrique Fertilite, 31:546-549, 2003. Abramowitz L. et.al. Anal fissures and thrombosed external hemorrhoids before and after delivery. Dis. Colon Rectum, 45:650-655, 2002. Brown S, Luley J. Maternal health after childbirth: Results of an australian population based survey. British Journal Obstet Gynaecol. 105(2):156-161, 1998. Byrd LM, Hobbiss J, Tasker M. Is it possible to predict or prevent third degree tears? Colorectal Disease. 7(4):311-318, 2005. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern, PM. Changes in women's physical health during first postpartum year. Arch Fam Med. 2:277-283, 1993. Cohen J. Statistical power analysis for the behavioral sciences. Second Edition. Hillsdale NJ: Lawrence Erlbaum Associates,Inc. 1988.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the success rate and assess the safety and efficacy of the HEM-AVERT™ instrument as a method of reducing the occurrence and/or severity of hemorrhoids and/or Thrombosed External Hemorrhoids (TEH), which commonly occur during vaginal delivery.		Screening(Baseline), Delivery , Follow-up at Discharge (Total = 3 to 4 months)	No
Secondary	Grade presence or absence, # present, % of circumference of anus involved and volume of burden of hemorrhoids before & after delivery in both groups. Compare the occurrence of lacerations, anal fissures, and C-Sections in both groups.		Screening(Baseline), Delivery, Follow-up at Discharge (Total = 3 to 4 months)	No